Buyouts
Portfolio: Affirma and Sunwoo Fresh
Affirma Capital is helping Korea’s Sunwoo Fresh discover new revenue streams overseas, online, and in adjacent links of the beef importing value chain. Aggressive M&A has accelerated the process
Deal focus: Baring Asia completes Interplex turnaround
Refocusing on high-growth segments like electric vehicles – plus a smarter approach to sales and operations – underpinned Baring Private Equity Asia’s 4x return on engineering business Interplex
CapVest tops BGH's bid for Australia's Virtus Health
CapVest Partners, a UK-headquartered private equity firm that primarily invests in Europe and North America, has entered the race for Australian fertility care business Virtus Health with an AUD 650.1m (USD 469m) offer.
Asia PE investment hits new high in 2021
A rebound in China-based activity took Asia private equity investment to a record USD 105.3bn in the fourth quarter, ensuring that 2021 represents a new high watermark for the industry.
4Q analysis: Record quarter, record year
China rebounds as Asia private equity investment ends 2021 with a bang; bright spots in improving fundraising environment; sponsor-to-sponsor exits thrive while PE-backed IPOs stumble
Deal focus: ACA seeks Asia-Europe sporting synergies
Japan’s ACA Group has acquired a Belgium-based KMSK Deinze as part of a multi-club investment strategy that will – in part – bring Asian players into the middle tiers of European football
Bain exits Japan hot spring operator to Lone Star
Bain Capital has sold Ooedo Onsen Monogatari Resorts & Hotels, a Japan-based traditional inn and hot spring chain operator it acquired nearly seven years ago, to Lone Star for an undisclosed sum.
MBK to buy control of Korea e-commerce solutions provider
MBK Partners has agreed to buy a controlling stake in KoreaCenter, a Korea-based e-commerce services provider, for KRW 491.7bn (USD 429.8m) across several equity and debt transactions.
PE consortium cuts 51job take-private offer by 28%
A private equity consortium pursuing a take-private of US-listed Chinese online recruitment platform 51job has cut its offer price by 28%, citing deteriorating market conditions, regulatory tightening in China, and the continuing impact of COVID-19.
India sports: In it to win it
Private equity interest in the commercialisation of sport globally is filtering through to India, with a couple of high-profile cricket deals. What other franchises and rights owners could be up for grabs?
FountainVest buys China QSR restaurant operator from EQT
FountainVest Partners has acquired China F&B Group (CFB), one of the master franchise operators for Papa John’s and Dairy Queen in mainland China, from EQT for an undisclosed sum.
Japan's ACA buys Belgian football club
Japanese fund manager ACA Investments has created a football-focused unit under its Singapore-based subsidiary and acquired a club that competes in the second tier of the Belgian league.
PE consortium backs New Zealand fertility business
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
KKR to buy Japan SME software provider from Orix
KKR has agreed to buy Yayoi, a Japan-based software developer that serves small and medium-sized enterprises (SMEs) from Orix Corporation.
Advent acquires China's largest medical capsule maker
Advent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), the largest medical capsule maker in China, for an undisclosed sum.
BGH makes $432m bid for Australia's Virtus Health
BGH Capital has submitted a take-private bid for Virtus Health, an Australia-based fertility care services provider, that values the business at approximately A$607.3 million ($432 million).
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
2021 in review: Boom time
Cheap debt and a desire for assets that deliver technology-driven growth have propelled Asia private equity investment to new highs and supported a resurgence in exits. But fundraising still fails to convince
Endeavor United to buy chemicals unit from Japan's Bridgestone
Endeavour United, a Japanese private equity firm established by the team behind turnaround investor Phoenix Capital, has agreed to buy Bridgestone Corporation’s chemical products solutions business for an undisclosed sum.
Blue Owl buys Asia-based placement agent
US alternative asset manager Blue Owl Capital has acquired Hong Kong placement agent Ascentium with a view to establishing a physical presence in the territory and pursuing a broader regional expansion.
Singapore's Aura acquires Australia vaccination player
Singapore-based Aura Private Equity has acquired a majority stake in Australian Vaccine Services (AVS), a leading provider of corporate flu vaccinations.
CVC backs take-private of Hong Kong-listed Razer
CVC Capital Partners is supporting a proposed founder-led privatization of Hong Kong-listed gaming hardware and software provider Razer that values the business at HK$24.7 billion ($3.17 billion).
Wise Road buys semiconductor assets from Taiwan's ASE
Wise Road Capital, a China-based private equity firm that focuses on high-tech investments, has agreed to buy a package of assets from Taiwan-listed semiconductor business ASE Technology Holding for $1.46 billion.
Portfolio: Dymon Asia and AMES
For all the hubbub about digital businesses taking flight during the pandemic, few categories saw as much upside as traditional medical waste disposal. Dymon Asia Private Equity is enjoying the ride